Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III]. Patients will be followed-up during a period of 06-08 weeks. The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in Yaoundé, Cameroon.
CARECA-CHF study is a non-randomized, prospective, single-arm study, multicentric study. Patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III] will be enrolled ambulatory. The program will take place during a period of 06-08 weeks.
The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in a resource-limited country.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stable CHF patients | Experimental | Stable CHF patients on stage II/III based on the New York Heart Failure classification |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CHF Patients | Other | Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education |
| Measure | Description | Time Frame |
|---|---|---|
| Change of VO2 max | Variation of VO2 max at baseline and the end of the study | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Variation in 6-minute walk test (6MWT) distance | Variation in 6MWT in meter distance from the baseline to week 6 or 8. By using pedometer | 8 weeks |
| Variation of duration of exercise and maximum load |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chris Nadège N Nganou-Gnindjio, MD, MAS | Yaounde Central Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dr Chris Nadège Nganou-Gnindjio | Yaoundé | BP: 35307 Bastos | Cameroon |
Not provided
Patients with stable CHF in stage II or III of the New York Heart Association.
Not provided
Not provided
Not provided
Not provided
variation in duration of exercise and maximum load expressed by watt power
| 8 weeks |
| Variation in level of anxiety and depression; | Difference in level of anxiety and depression assessed by a questionnaire | 8 weeks |
| Change in quality of life assessed by the Minnesota Living With Heart Failure Questionnaire (MLWHFQ) | Change in quality of life assessed by the Minnesota Living With Heart Failure Questionnaire (MLWHFQ) Minnesota Living With Heart Failure Questionnaire score at Week 8 adjusted for baseline | 8 weeks |
| Variation of time-domain heart rate variability (HRV) parameters | Variation of time-domain heart rate variability parameters before and after the intervention | 8 weeks |
| Variation of frequency-domain HRV parameters | variation of frequency-domain HRV parameters before and after the intervention. Variation of frequency-domain HRV parameters (HF, LF, LF/HF) before and after the intervention. | 8 weeks |
| Variation of index hypopnea-apnea index | Variation of variation of index hypopnea-apnea after 6-8 weeks of aerobic training. | 8 weeks |
| Variation of sleep quality index | variation of sleep quality index by Pittsburg questionnaire | 8 weeks |
| Variation of nocturnal saturation | Variation of nocturnal saturation by oxymeter | 8 weeks |
| Non adherence | evaluation of non adherence by questionnaire at the end of the study | 8weeks |